Ketamine-Assisted Group Therapy for Work-Related Stress in First Responders and Frontline Health Care Workers
Luke Flynn, Mary Rondeau, Martin Krsak, Scott Shannon
Psychedelic Medicine April 21, 2025 DOI: 10.1089/psymed.2024.0050 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Pre-post intervention study Peer reviewed |
|---|---|
| Sample size | 16 |
| Population | First responders and frontline health care workers with work-related stress |
| Intervention | Ketamine-assisted psychotherapy |
| Duration | 6-week intervention |
| Topics | Ketamine Esketamine |
| Keywords | Health care Nursing Clinical psychology |
| Citations | 1 |
| Key points | Symptoms of trauma, anxiety, and depression were significantly reduced after a 6-week group ketamine-assisted psychotherapy program. |
Abstract
Introduction: Ketamine is an evidenced-based treatment for depression, and it has shown promise in addressing many other mental health conditions related to work-related stress or burnout, such as anxiety and post-traumatic stress disorder. Ketamine-assisted psychotherapy (KAP) is part of an emerging model of psychedelic medicine that employs psychoactive agents to support the psychotherapeutic process. Frontline health care workers and first responders encountered excessive levels of job stress, especially during the COVID-19 pandemic. This article reports on a 6-week community-based group-KAP program to address symptoms of trauma, anxiety, and depression in a sample of first responders and frontline health care workers.
Methods: Recruitment was self-directed based on a sense of work-related stress. All participants completed a 6-week ketamine-assisted psychotherapy group intervention with three to six participants per group. The group characteristics and repeated measures comparisons were analyzed via descriptive statistics, pre- and post-intervention measure comparisons and regression modeling.
Results: Sixteen patients received KAP in small groups with “pre” and “post” treatment evaluation of anxiety (Generalized Anxiety Disorder–7), depression (Patient Health Questionnaire–9), and trauma (Posttraumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition). Symptoms of trauma, anxiety, and depression were significantly reduced ( p < 0.002) from “pre” to “post” test.
Conclusion: These results suggest that the community-based group-KAP program described here may be a useful treatment for work-related stress, though further formal evaluation is required. Future directions, limitations, and interpretations are discussed.
Comparable studies
Other non-randomized and open-label trials on ketamine, most cited first.
Citations in the library
Cited by 2
- Ketamine-Assisted Therapy Outcomes for First Responders With Comorbid Mental Health Diagnoses Journal of Occupational and Environmental Medicine October 17, 2025
- Group psychedelic-assisted therapy for mental health conditions: a mixed-methods systematic review Frontiers in Public Health October 6, 2026
Cites 21
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Science August 19, 2010
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation American Journal of Psychiatry March 17, 2021
- Global Street Food: la cocina de la calle Diseño interior 2009
- Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Biological Psychiatry February 1, 2023
and 16 more in the library